A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer | MicrobiomeTrials← Back to trialsNCT07335796
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-01-09Est. Completion: 2030-01-09
Enrollment target: 7 participants Locations- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States
Other microbiome trials you might be interested in
Prostate CancerRecurrent Prostate CancerMetastatic Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic
This is a randomized, open-label, pilot study assessing the impact of a short course of bicalutamide on PSMA expression …
St Louis, United StatesEst. completion Nov 14, 2027
Prostate Cancer
Prostate cancer is the most frequently diagnosed cancer among men over 50 years old in Western societies, with an incide…
Hackensack, United StatesCompleted Oct 1, 2026
Recurrent Prostate CancerProstate Cancer
Background:
Biochemically recurrent prostate cancer (BCR) occurs when prostate-specific antigen (PSA) levels in the blo…
Bethesda, United StatesEst. completion Jan 30, 2029